Automating MS Analysis of Therapeutic Oligonucleotide Biotransformations

In this case study, reaserachers from Novartis developed and implemented an automated solution for processing, analyzing, and reporting MS data that enables comprehensive insights into the metabolism of oligonucleotide therapeutics while delivering significant time savings.